CD33 and myelodysplastic syndrome: In line with these data, it has also been reported that the levels of IL-10 and TGFβ1 produced by Lin−/CD33+/ DR− MDSCs are increased in high-risk MDS patients, implying their possible prognostic value in patients with MDS [92].